Drug supplier receives $3.45 billion in commitment in new financing.
As part of a financial restructuring agreement with its senior secured noteholders, Rite Aid announced that it has filed for Chapter 11 bankruptcy. Reportedly, the plan will enable the company to speed up its ongoing business transformation by reducing debt, increasing financial flexibility, and enabling the execution of key initiatives.
Rite Aid credits the court-supervised process with providing the ability to:
“Rite Aid has served customers and communities across our country for more than 60 years, and the important actions we are taking today will enable us to move ahead as a stronger company,” said Jeffrey S. Stein, Rite Aid’s new CEO, in a company press release. “With the support of our lenders, we look forward to strengthening our financial foundation, advancing our transformation initiatives and accelerating the execution of our turnaround strategy. In doing so, we will be even better able to deliver the healthcare products and services our customers and their families rely on – now and into the future.”
Reference: Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success. Rite Aid. October 15, 2023. Accessed October 16, 2023. https://news.riteaid.com/press-releases/press-release-details/2023/Rite-Aid-Takes-Steps-to-Accelerate-Transformation-and-Position-Company-for-Long-Term-Success/default.aspx
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.